Wanis Kerollos Nashat, Sarvet Aaron L, Wen Lan, Block Jason P, Rifas-Shiman Sheryl L, Robins James M, Young Jessica G
Department of Epidemiology, Harvard T. H. Chan School of Public Health, 677 Huntington Ave, Kresge 9th, Boston, MA, USA.
Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
J R Stat Soc Ser A Stat Soc. 2024 Jan 22;187(3):796-810. doi: 10.1093/jrsssa/qnae002. eCollection 2024 Aug.
Researchers are often interested in estimating the effect of sustained use of a treatment on a health outcome. However, adherence to strict treatment protocols can be challenging for individuals in practice and, when non-adherence is expected, estimates of the effect of sustained use may not be useful for decision making. As an alternative, more relaxed treatment protocols which allow for periods of time off treatment (i.e. grace periods) have been considered in pragmatic randomized trials and observational studies. In this article, we consider the interpretation, identification, and estimation of treatment strategies which include grace periods. We contrast grace period strategies which allow individuals the flexibility to take treatment as they would naturally do, with grace period strategies in which the investigator specifies the distribution of treatment utilization. We estimate the effect of initiation of a thiazide diuretic or an angiotensin-converting enzyme inhibitor in hypertensive individuals under various strategies which include grace periods.
研究人员通常对评估持续使用某种治疗方法对健康结果的影响感兴趣。然而,在实际中,坚持严格的治疗方案对个体来说可能具有挑战性,而且当预期会出现不依从情况时,持续使用治疗方法的效果估计可能对决策没有帮助。作为一种替代方法,在务实的随机试验和观察性研究中,已经考虑了更宽松的治疗方案,这种方案允许有不进行治疗的时间段(即宽限期)。在本文中,我们考虑包含宽限期的治疗策略的解释、识别和估计。我们将允许个体根据自身自然情况灵活接受治疗的宽限期策略,与研究者指定治疗使用分布的宽限期策略进行对比。我们估计在各种包含宽限期的策略下,高血压个体开始使用噻嗪类利尿剂或血管紧张素转换酶抑制剂的效果。